Acamprosate Calcium - NDC Database

12 records found

Page:1

0258-4000 Jan 11, 2005
Acamprosate Calcium 333 mg (Acamprosate 300 mg) Enteric Coated Tablet by Forest Laboratories, Inc.

0378-6333 Sep 24, 2014
Acamprosate Calcium 333 mg Oral Tablet, Delayed Release by Mylan Pharmaceuticals Inc.

60687-121 Oct 27, 2015
Acamprosate Calcium 333 mg Oral Tablet, Delayed Release by American Health Packaging

68462-435 Jul 16, 2013
Acamprosate Calcium 333 mg (Acamprosate 300 mg) Enteric Coated Tablet by Glenmark Generics Inc., USA

10135-636 Aug 01, 2016
Acamprosate Calcium 333 mg Oral Tablet, Delayed Release by Marlex Pharmaceuticals Inc

51079-241 Oct 22, 2014
Acamprosate Calcium 333 mg Oral Tablet, Delayed Release by Mylan Institutional Inc.

69189-0437 Aug 17, 2015
Acamprosate Calcium 333 mg Oral Tablet, Delayed Release by Avera Mckennan Hospital

0093-5352 Mar 25, 2016
Acamprosate Calcium 333 mg Oral Tablet, Delayed Release by Teva Pharmaceuticals USA Inc

0904-7213 Jul 16, 2013
Acamprosate Calcium 333 mg Oral Tablet, Delayed Release by Major Pharmaceuticals

42291-104 May 16, 2016
Acamprosate Calcium 333 mg Oral Tablet, Delayed Release by Avkare, Inc.

68382-569 Jun 01, 2017
Acamprosate Calcium 333 mg Oral Tablet, Delayed Release by Zydus Pharmaceuticals (Usa) Inc.

70771-1057 Jun 01, 2017
Acamprosate Calcium 333 mg Oral Tablet, Delayed Release by Cadila Healthcare Limited

Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.